CRISPR/Cas9 pi­o­neer Chad Cow­an en­lists in Mus­tang Bio’s CAR-T quest

The tech race spawned by a block­buster scram­ble to the top of the emerg­ing CAR-T sec­tor has in­spired a tie-up be­tween one of the pi­o­neer­ing sci­en­tists in­volved with CRISPR/Cas9 gene edit­ing and an up-and-com­er can­cer drug de­vel­op­er that is work­ing on a game plan to over­take the lead­ers — which are way out front right now.

The sci­en­tist is Chad Cow­an, a re­searcher at the Har­vard Stem Cell In­sti­tute who al­lied ear­ly on with the CRISPR/Cas9 team that launched CRISPR Ther­a­peu­tics un­der gene edit­ing star Em­manuelle Char­p­en­tier.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.